Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Graft vs Host Disease × Alemtuzumab × 90 days × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Clear Cell 1

Interventions

ruxolitinib 4 Cyclophosphamide 4 Mycophenolic Acid 3 fludarabine 2 Tacrolimus 2 Methotrexate 2 Busulfan 2 blinatumomab 1 belumosudil 1 axatilimab 1 Whole-Body Irradiation 1 Vorinostat 1 Thiotepa 1 Sirolimus 1 Panobinostat 1 Low-Level Light Therapy 1 Interferon-gamma 1 Cyclosporine 1 Clofarabine 1 Blood Specimen Collection 1 Biopsy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡